Stay updated on Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check43 days agoChange DetectedSite platform updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision banner updated to v3.4.2; the previous notices about funding lapses and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedA site-wide notice about government funding delays and current operating status is added, and the page shows a revision update to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check86 days agoChange DetectedThe page now includes a Show glossary toggle and new metadata labels: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.